These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 8708753)

  • 21. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics of metronidazole determined by a time-kill assay for Trichomonas vaginalis.
    Nix DE; Tyrrell R; Müller M
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1848-52. PubMed ID: 7486930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of metronidazole-resistant Trichomonas vaginalis in a gynecology clinic.
    Schmid G; Narcisi E; Mosure D; Secor WE; Higgins J; Moreno H
    J Reprod Med; 2001 Jun; 46(6):545-9. PubMed ID: 11441678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of Trichomonas vaginalis to metronidazole and treatment outcome in vaginal trichomoniasis.
    Müller M; Lossick JG; Gorrell TE
    Sex Transm Dis; 1988; 15(1):17-24. PubMed ID: 3258675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Adagu IS; Nolder D; Warhurst DC; Rossignol JF
    J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
    Bouma MJ; Snowdon D; Fairlamb AH; Ackers JP
    J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metronidazole-resistant strains of Trichomonas vaginalis display increased susceptibility to oxygen.
    Rasoloson D; Tomková E; Cammack R; Kulda J; Tachezy J
    Parasitology; 2001 Jul; 123(Pt 1):45-56. PubMed ID: 11467782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tinidazole therapy for metronidazole-resistant vaginal trichomoniasis.
    Sobel JD; Nyirjesy P; Brown W
    Clin Infect Dis; 2001 Oct; 33(8):1341-6. PubMed ID: 11565074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenical pessaries in the treatment of metronidazole-resistant Trichomonas vaginalis.
    Walker PP; Hall RE; Wilson JD
    Int J STD AIDS; 1997 Jul; 8(7):473. PubMed ID: 9228600
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of the effect of a plant alkaloid (berberine derived from Berberis aristata) on Trichomonas vaginalis in vitro.
    Soffar SA; Metwali DM; Abdel-Aziz SS; el-Wakil HS; Saad GA
    J Egypt Soc Parasitol; 2001 Dec; 31(3):893-904 + 1p plate. PubMed ID: 11775115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of metronidazole resistance in a population of Trichomonas vaginalis clinical isolates.
    Snipes LJ; Gamard PM; Narcisi EM; Beard CB; Lehmann T; Secor WE
    J Clin Microbiol; 2000 Aug; 38(8):3004-9. PubMed ID: 10921968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vitro studies on the identification of metronidazole resistant strains of Trichomonas vaginalis (author's transl)].
    Meingassner JG; Stockinger K
    Z Hautkr; 1981 Jan; 56(1):7-15. PubMed ID: 6971538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three metronidazole-resistant strains of Trichomonas vaginalis from the United States.
    Müller M; Meingassner JG; Miller WA; Ledger WJ
    Am J Obstet Gynecol; 1980 Dec; 138(7 Pt 1):808-12. PubMed ID: 7004190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activities of dicationic compounds against Trichomonas vaginalis.
    Crowell AL; Stephens CE; Kumar A; Boykin DW; Secor WE
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3602-5. PubMed ID: 15328138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of hexadecylphosphocholine (miltefosine) against metronidazole-resistant and -susceptible strains of Trichomonas vaginalis.
    Blaha C; Duchêne M; Aspöck H; Walochnik J
    J Antimicrob Chemother; 2006 Feb; 57(2):273-8. PubMed ID: 16344287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichomonads, hydrogenosomes and drug resistance.
    Kulda J
    Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An in vitro metronidazole susceptibility test for trichomoniasis using the InPouch TV test.
    Borchardt KA; Li Z; Zhang MZ; Shing H
    Genitourin Med; 1996 Apr; 72(2):132-5. PubMed ID: 8698362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trichomonacidal activity of newly synthesized derivatives of benzoizothiazolinon (BIT) in vitro].
    Ziomko I; Kuczyńska E
    Wiad Parazytol; 1994; 40(1):59-64. PubMed ID: 8023507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Trichomonas vaginalis strains to metronidazole: response to treatment.
    Ralph ED; Darwish R; Austin TW; Smith EA; Pattison FL
    Sex Transm Dis; 1983; 10(3):119-22. PubMed ID: 6359490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetarsol pessaries in the treatment of metronidazole resistant Trichomonas vaginalis.
    Chen MY; Smith NA; Fox EF; Bingham JS; Barlow D
    Int J STD AIDS; 1999 Apr; 10(4):277-80. PubMed ID: 12035784
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.